Literature DB >> 17067662

The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva.

Destin Black1, Carmen Tornos, Robert A Soslow, Christopher S Awtrey, Richard R Barakat, Dennis S Chi.   

Abstract

OBJECTIVES: Vulvar Paget's disease is a rare neoplasm that usually occurs in postmenopausal women. Treatment with surgical excision can be complicated by extension of microscopic disease in an irregular manner well beyond the visible margins of the lesion. The objective or our study was to analyze the outcomes of patients with primary vulvar intraepithelial Paget's disease who had positive microscopic margins after primary excision.
METHODS: We reviewed the records of all patients with Paget's disease of the vulva treated at our institution from 1/80 to 9/02. Patients whose sample showed stromal invasion or an underlying carcinoma were excluded. Data were collected regarding patient demographics, disease location, treatment, surgical margin status, additional treatment, and clinical outcome.
RESULTS: The medical records and histopathologic specimens of 28 women with intraepithelial Paget's disease of the vulva were evaluated. Surgical treatment consisted of radical vulvectomy in 3 patients (11%), simple vulvectomy in 18 patients (64%), and wide local excision in the other 7 patients (25%). Of the 20 patients with microscopically positive margins, 14 (70%) developed recurrent disease and the remaining 6 (30%) are disease free. Of the 8 patients with negative margins, 3 (38%) developed disease recurrence and the remaining 5 (63%) are disease free. With a median follow-up of 49 months (range, 3-186 months), there was no correlation between disease recurrence and margin status (P=0.20). Of the 17 patients who recurred, 14 (82%) underwent additional surgical excision and 1 patient was treated with Retin-A. The remaining 2 patients refused further treatment and were lost to follow-up. In those patients who underwent surgery for recurrence, between 1 and 3 re-excisions were performed. Of the 15 evaluable patients who were treated for recurrent disease, 12 (80%) had no evidence of persistent disease and 3 (20%) had persistent disease at a median follow-up of 63.7 months (range, 18.5-186 months).
CONCLUSIONS: Microscopically positive margins following surgical excision of vulvar intraepithelial Paget's disease is a frequent finding, and disease recurrence is common regardless of surgical margin status. Long-term monitoring of patients is recommended, and repeat surgical excision is often necessary.

Entities:  

Mesh:

Year:  2006        PMID: 17067662     DOI: 10.1016/j.ygyno.2006.09.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  18 in total

1.  Clinical research of holmium laser therapy in extramammary Paget's disease.

Authors:  Li Ziyao; Yang Deyong; Che Xiangyu; Zong Huafeng; Adnan Hafeez; Wang Jianbo; Song Xishuang
Journal:  Lasers Med Sci       Date:  2014-06-08       Impact factor: 3.161

Review 2.  A primer on extramammary Paget's disease for the urologist.

Authors:  Joon Yau Leong; Paul H Chung
Journal:  Transl Androl Urol       Date:  2020-02

3.  Paget's disease of the vulva: a clinicopathologic institutional review.

Authors:  Alberto A Mendivil; Lisa Abaid; Howard D Epstein; Mark A Rettenmaier; John V Brown; John P Micha; Marie A Wabe; Bram H Goldstein
Journal:  Int J Clin Oncol       Date:  2011-10-01       Impact factor: 3.402

Review 4.  Effects of imiquimod on vulvar Paget's disease: a systematic review of literature.

Authors:  Hiroko Machida; Aida Moeini; Lynda D Roman; Koji Matsuo
Journal:  Gynecol Oncol       Date:  2015-07-17       Impact factor: 5.482

5.  Vulvar's Paget's disease treated with a combination of clock mapping and imiquimod.

Authors:  Christos Iavazzo; Ioannis Gkegkes; Alexandros Fotiou
Journal:  Arch Gynecol Obstet       Date:  2022-10-15       Impact factor: 2.493

6.  The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.

Authors:  Mario Preti; Elmar Joura; Pedro Vieira-Baptista; Marc Van Beurden; Federica Bevilacqua; Maaike C G Bleeker; Jacob Bornstein; Xavier Carcopino; Cyrus Chargari; Margaret E Cruickshank; Bilal Emre Erzeneoglu; Niccolò Gallio; Debra Heller; Vesna Kesic; Olaf Reich; Colleen K Stockdale; Bilal Esat Temiz; Linn Woelber; François Planchamp; Jana Zodzika; Denis Querleu; Murat Gultekin
Journal:  J Low Genit Tract Dis       Date:  2022-06-21       Impact factor: 3.842

7.  A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease.

Authors:  Renee A Cowan; Destin R Black; Lien N Hoang; Kay J Park; Robert A Soslow; Floor J Backes; Ginger J Gardner; Nadeem R Abu-Rustum; Mario M Leitao; Eric L Eisenhauer; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2016-05-05       Impact factor: 5.482

8.  Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget's Disease of the Vulva.

Authors:  Marina Stasenko; Gowtham Jayakumaran; Renee Cowan; Vance Broach; Dennis S Chi; Anthony Rossi; Travis J Hollman; Ahmet Zehir; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  JCO Precis Oncol       Date:  2020-09-15

9.  Paget's Disease of the Vulva in Premenopausal Woman Treated with Only Surgery: A Case Report.

Authors:  Hamid Asmouki; Rachid Oumouloud; Abderrahim Aboulfalah; Abderraouf Soummani; Abdelouahed Marrat
Journal:  Case Rep Oncol Med       Date:  2012-09-16

10.  Interventions for the treatment of Paget's disease of the vulva.

Authors:  Katharine A Edey; Ernest Allan; John B Murdoch; Susan Cooper; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.